An endogenous NOS inhibitor
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NG,NG-dimethyl-L-Arginine (hydrochloride)

Item No. 80230

Technical Information
Formal Name
N5-[(dimethylamino)iminomethyl]-L-ornithine, dihydrochloride
CAS Number
220805-22-1
Synonyms
  • ADMA
  • Asymmetric dimethylarginine
Molecular Formula
C8H18N4O2 • 2HCl
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 5 mg/mlDMSO: 3 mg/mlEthanol: 3 mg/mlPBS (pH 7.2): 20 mg/mlWater: 20 mg/ml
SMILES
OC(=O)[C@@H](N)CCCNC(=N)N(C)C
InChi Code
InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)
InChi Key
YDGMGEXADBMOMJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    NG,NG-dimethyl-L-arginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS).1,2 It is formed from arginine by protein arginine methyltransferases (PRMTs) and degraded by dimethylarginine dimethylaminohydrolases (DDAHs) and alanine-glyoxylate aminotransferase 2 (AGXT2).1 ADMA levels are increased concomitant with an increase in blood pressure in Dahl salt-sensitive rats fed a high-salt diet.2 ADMA levels are increased in the plasma in a variety of endothelial dysfunction-related diseases, including hypertension, congestive heart failure, and end-stage renal disease.1,3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sydow, K., and Münzel, T. ADMA and oxidative stress. Atheroscler. Suppl. 4(4), 41-51 (2003).

    2. Jin, J.S., and D'Alecy, L.G. Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. J. Cardiovasc. Pharmacol. 28(3), 439-446 (1996).

    3. Vallance, P., Leone, A., Calver, A., et alAccumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339(8793), 572-575 (1992).

    4. Matsuoka, H., Itoh, S., Kimoto, M., et alAsymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 29(1 Pt 2), 242-247 (1997).